We are live on
!
Find out more
AIC
Argus Investors Counsel Portfolio holdings
AUM
$130M
1-Year Est. Return
37.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.1%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$246M
AUM Growth
-$1.69M
(-0.68%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-7.87%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
94
New
9
Increased
23
Reduced
50
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$769K |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$545K |
| 3 |
UnitedHealth
UNH
|
+$353K |
| 4 |
Allstate
ALL
|
+$326K |
| 5 |
Nasdaq
NDAQ
|
+$323K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nucor
NUE
|
+$2.49M |
| 2 |
NVIDIA
NVDA
|
+$1.26M |
| 3 |
Blackrock
BLK
|
+$1.13M |
| 4 |
Corning
GLW
|
+$737K |
| 5 |
Texas Instruments
TXN
|
+$707K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.17% |
| 2 | Financials | 15.73% |
| 3 | Healthcare | 13.78% |
| 4 | Industrials | 11.95% |
| 5 | Consumer Staples | 10.02% |
Similar funds
NCM
CG
MWM
EPCA
DSC
CWAI
RHIG
WM
Argus Investors Counsel's Q2 2021 Portfolio in Review
As of Q2 2021, Argus Investors Counsel held 94 positions worth $246M, down 0.68% from $248M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Argus Investors Counsel withdrew a net $19.3M in Q2 2021, closing 2 positions and reducing 50 holdings. Its most notable exit was Emergent Biosolutions, an estimated $661K position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Argus Investors Counsel opened a new position in UnitedHealth worth $355K.
- Argus Investors Counsel's largest Q2 2021 buy was UnitedHealth: 886 shares worth $355K.
- Argus Investors Counsel added most to S&P Global in Q2 2021, an estimated $769K increase.
- Argus Investors Counsel's biggest Q2 2021 reduction was Nucor, cutting an estimated $2.49M.
- Argus Investors Counsel fully exited Emergent Biosolutions in Q2 2021, selling an estimated $661K.
- Argus Investors Counsel's ten largest holdings make up 24% of its $246M portfolio in Q2 2021.
- Argus Investors Counsel opened 9 new positions and closed 2 in Q2 2021.
- Argus Investors Counsel's portfolio value fell 0.68% quarter-over-quarter to $246M.
Based on Argus Investors Counsel's 13F filing for Q2 2021, filed 30 Jul 2021.